Wednesday 2nd December 2020

(3 years, 4 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

The hon. Lady shakes her head, but that is how we have to deal with a pandemic in practice.

Jeremy Hunt Portrait Jeremy Hunt (South West Surrey) (Con)
- Hansard - -

This is a huge personal triumph for the Health Secretary, who has always backed the science. In choosing and backing on behalf of the country the first vaccine to prove efficacious, he has scored a massive goal for the country; he deserves great credit for that. It will also have global significance. I was in a meeting with the World Health Organisation this morning, which congratulated the UK on being the first country to approve a vaccine, because it will encourage other countries around the world to approve vaccines faster.

I want to ask the Health Secretary about something different, which is the plight of people with learning disabilities. He will know that Public Health England says that they are two to four times more likely to die from covid. The news he has given this morning about people in care homes is tremendously welcome, but people with learning disabilities often feel that they are forgotten, particularly those in supported accommodation. Will he redouble his efforts to ensure that they, too, are able to be reunited with their families ahead of Christmas?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

My right hon. Friend is gracious and kind in what he says, and I welcome the WHO’s comments this morning. It has supported the UK approach and rightly commended the MHRA, our independent regulator. It has followed all the same steps that any high-quality regulator would, should and will, but it has followed them rapidly and sometimes in parallel, instead of one after the other. That is how we have got to the position of being the first country in the world to have a vaccine that is clinically authorised; it is because the MHRA has done a brilliant job, working with Pfizer and BioNTech, to make sure that the same safety considerations are looked at but in a way that made the process as fast as is feasibly and safely possible. The WHO has backed that approach. Regulators around the world could take a look at the MHRA, and we should all congratulate it.

My right hon. Friend rightly asks about making sure we vaccinate those with learning disabilities and offer them vaccination at the right point in the prioritisation. I have discussed that important consideration directly with the JCVI, which takes into account the higher mortality of those with any given condition and has done so in the prioritisation that it set out this morning. Age is the single biggest determinant of mortality from coronavirus, which is why age is the predominant factor in the prioritisation, but it is not the only one. That matter has been considered by the JCVI and it is important that we accept and follow the JCVI advice as much as is practicable in the delivery and deployment of this vaccine.